Skip to main content
Full access
Letters
Published Online: 1 July 2012

Probable Aripiprazole-Induced Tardive Writer's Cramp

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Writer's cramp is the most commonly identified tasks-specific focal dystonia of writing, characterized by abnormal muscle spasm of hand and arm.1 We report on a patient in whom writer's cramp developed after 8 months of treatment with aripiprazole. To the best of our knowledge, probable aripiprazole-induced tardive writer's cramp has never been described on the literature that has been reported.

Case Report

Mr. A was a 19-year-old right-handed male high school student with a 4-year history of DSM-IV paranoid schizophrenia. At age 15, he presented with auditory hallucinations, persecutory delusions, delusions of reference, and decreased social interaction. Sulpiride, 400 mg/day, was administered for 2 years, but decreased social interaction and delusions of reference remained. We replaced sulpiride, 400 mg/day, with aripiprazole, 12 mg/day. This switching led to complete remission of his schizophrenic symptoms and he had no adverse event. Afterward he studied hard to take a university entrance examination. Eight months after aripiprazole therapy, he complained that it was hard to write because of a stiffening of his right hand, and these episodes occurred whenever he was willing to write. He showed tight grip of the pen, hyperflexion at wrist joint, flexion at elbow joint, and abduction at shoulder joint when writing. He had no abnormal findings on hematology tests, biochemistry tests, magnetic resonance imaging of the brain, and electroencephalography. He had no other movement disorders except for these symptoms. He also had no family history of dystonia or other movement disorders. His symptoms were diagnosed by neurologists as a writer's cramp. The dosage of aripiprazole was gradually decreased and completely discontinued without recurrence of his psychosis. Despite withdrawal of aripiprazole, he still has these symptoms during 6-month follow up.

Discussion

Our patient had no episode of writer's cramp in the past when he was exposed to the classical antipsychotic sulpiride; nevertheless he developed this movement disorder while on aripiprazole therapy. He had two well known risk factors for dystonia, i.e. being young and male.2 He also fulfilled the criteria for tardive dystonia involving presence of chronic dystonia, history of antipsychotic drug treatment, negative family history for dystonia, and exclusion of known causes of secondary dystonia.3 Moreover, it appears that his writer's cramp developed as a form of tardive dystonia not only because of its late appearance but also due to its characteristic persistence following removal of the offending agent. It was recently reported that the writer's cramp could be caused by atypical neuroleptics like risperidone and olanzapine in young patients.4,5 Since aripiprazole exhibits a pharmacological effect different from that of other atypical antipsychotics and typical antipsychotics, it has been considered to be less likely to cause tardive dystonia than other neuroleptics. However, we suggested that aripiprazole can induce a writer's cramp in young male patient and that it may be very difficult to achieve complete remission. The pathophysiological basis of writer's cramp remains obscure. Therefore, the new neuroleptic should be administered with the same caution as conventional agents.

References

1.
Torres-Russotto D, Perlmutter JS: Task-specific dystonias: a review. Ann N Y Acad Sci 2008; 1142:179–199
2.
Marsálek M: Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry 2000; 33(Suppl 1):14–33
3.
Burke RE, Fahn S, Jankovic J, et al.: Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32:1335–1346
4.
Aggarwal A, Khandelwal A, Garg A, et al.: Probable risperidone-induced tardive "writer's dystonia". Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:721
5.
Vaamonde J, González JM, Hernádez A, et al.: Writer's cramp induced by olanzapine. J Neurol 2001; 248:422

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E44
PubMed: 23037681

History

Published online: 1 July 2012
Published in print: Summer 2012

Authors

Details

Kazuhiro Sato, M.D., Ph.D.
Keizo Yoshida, M.D., Ph.D.
Hisashi Higuchi, M.D., Ph.D.

Notes

Department of Psychiatry, Akita Kaiseikai Hospital, Akita, Japan
Department of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan
Department of Neuropsychiatry, St Marianna University School of Medicine, Kanagawa, Japan

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share